An interventional study of Senna and Sodium Picosulfate, Magnesium Oxide and Citric Acid in Colostomy, Hirschsprung Disease - Pull Through and Necrotizing Enterocolitis, sponsored by McMaster University. Status unknown. Open to participants aged 3 Months to 18 Years. Per ClinicalTrials.gov, last updated 2021-12-09.
Sponsored by McMaster University · Not applicable, Interventional, and Prevention
Infections after elective intestinal surgery remain a significant burden for patients and for the health care system. The cost of treating a single surgical site infection is estimated at approximately $27,000. In adult patients, there is good evidence that the combination of oral antibiotics and mechanical bowel preparation is effective at reducing infections after intestinal surgery. In children, the body of evidence is much weaker. In this population, little evidence exists for oral antibiotics reducing infections and no data exists as to the effect of combining antibiotics with mechanical bowel preparation (such as polyethylene glycol (PEG)). The goal of the proposed study is to examine the effects of oral antibiotics with and without the combined use of mechanical bowel preparation on the rate of post-operative infectious complications in children aged 6 months to 18 years. This will be compared to the institution's current standard of care, which is to abstain from any type of mechanical bowel preparations or oral antibiotic administration before intestinal surgery.
Background:
A Cochrane review of randomized controlled trials of MBP use in adults showed no difference in the rate of wound infection or anastomotic leak in colon or rectal procedures with MBP compared to no preparation (Guenaga, Matos, \& Wille-Jorgensen, 2011). Two recent systematic reviews and meta-analyses support those findings. Lok and colleagues (2018) identified two randomized controlled trials and four retrospective reviews for patient \<21 years, looking at preoperative MBP and its effect on the incidence postoperative complications, including anastomotic leak, wound infection, and intra-abdominal infection (Janssen Lok M 2018). Overall, MBP before colorectal surgery did not significantly decrease the incidence of post-operative outcomes. This was consistent with findings from a systematic review in mechanical bowel preparation in pediatric population. The review showed that the risk of developing a post-operative infection was 10.1% in patients who received MBP compared to 9.1% in patients who did not receive MBP, resulting in no statistically significant difference difference (risk difference of -0.03% (95% CI, -0.09% - 0.03%)) (Zwart 2018).
With regards to OA alone, the adult literature showed promising results in favour of the OA. In a Cochrane review on antimicrobial prophylaxis in colorectal surgery, the addition of OA to the intravenous antibiotics was found to reduce surgical wound infection (RR 0.56, 95% CI 0.43 to 0.74) (Nelson, Gladman, \& Barbateskovic, 2014).
There are fewer studies in the pediatric population on the subject, they contain fewer patients and are mainly retrospective in nature. In a multi-center retrospective study, Serrurier et al. (2012), reviewed outcomes in children who underwent colostomy closure, and found higher rates of wound infection (14% vs. 6%, p=0.04) and a longer hospital length of stay in children who received MBP. In a retrospective cohort study including 1581 pediatric patients from PHIS database, post-operative complications were found to be highest in the no preparation group compared to combination prep and OA alone (23.3%, 15.9%, and 14.2% respectively; p=0.002) (Ares 2018). One study compared MBP alone versus MBP with OA in children undergoing colostomy closure post anorectal malformation repair and found no difference in overall SSI rates (MBP+OA: 13% (7/53) versus MBP alone: 17% (7/12) p=0.64) (Breckler, Rescorla, \& Billmire, 2010). The authors found that the use of MBP alone was associated with a greater risk of wound infection (14% vs. 6%, p=0.04) and a longer hospital stay. Evidence to support the sole use of oral antibiotics versus in combination with MBP is lacking, particularly in the pediatric literature, with more studies being required to address this question.
One recent meta-analysis including adults assessed 8458 adult patients (38 clinical trials), comparing 4 groups of different bowel preparation: MBP with OA, OA only, MBP only, and no preparation. The primary outcome was the total rate of incisional and organ/space SSIs. Results showed that only MBP with OA versus MBP alone was associated with a statistically significant reduction in SSI rates. The use of OA without MBP was not associated with a statistically significant reduction in SSI rates when compared to any other group. The authors concluded that MBP with OA was associated with the lowest risk of SSI, followed by OA only (Toh et al., 2018).
It remains unclear whether the addition of MBP to OA in pediatric population affects the rate of post-operative infectious complications positively or negatively. The current study is therefore needed to build on the work conducted in the adult literature to determine best practices for the pediatric population.
Purpose:
This is a pilot study to check the feasibility of conducting a randomized controlled trial to assess the efficacy of oral nonabsorbable antibiotics, with or without mechanical bowel preparation, in reducing the rate of post-operative infectious complications occurring within 30 days post-operatively in children and adolescents (aged 6 months to 18 years) undergoing elective colon or rectal surgery.
Post-operative complications include: surgical site infections (incisional, organ-space, and anatomic leak), length of hospital stay, readmission, post-operative use of therapeutic antibiotics, re-operation, occurrence of electrolyte disturbances (in case MBP was used), and occurrence of C. difficile infection.
1,460 studies on the registry are indexed under Inflammatory Bowel Diseases; 437 are open to participants now.
This study's planned enrollment of 81 is above the median of 70 across 770 interventional studies indexed under Inflammatory Bowel Diseases.
Browse Inflammatory Bowel Diseases studies →McMaster University is the lead sponsor of 720 studies on the registry; 124 are open to participants now.
Of its 6 completed or terminated interventional studies of FDA-regulated products, 2 (33%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Procedures that would not require mechanical bowel preparation:
Patients will received mechanical bowel preparation (age appropriate dose, starting 2 days before surgery) and prophylactic oral antibiotics (3 doses, 1 day before surgery). Clear fluids (or breast milk if applicable) will be given starting day before surgery. The standard care will also be delivered (NPO for anesthesia and intravenous antibiotics on induction) Patients/parents will be provided with stool diary to document the adequacy of preparation. This will include frequency and character of stool according to Bristol grade. The treating surgeon will rate the adequacy of the preparation intra-operatively.
Drug: Senna · Drug: Sodium Picosulfate, Magnesium Oxide and Citric Acid · Drug: Metronidazole Oral · Drug: Neomycin · Drug: Cefazolin · Drug: Metronidazole · Other: Nil per os · Other: Clear fluids the day before surgery
The patients will receive prophylactic oral antibiotics (3 doses, 1 day before surgery)as well as standard care (NPO for anesthesia and intravenous antibiotics on induction).
Drug: Metronidazole Oral · Drug: Neomycin · Drug: Cefazolin · Drug: Metronidazole · Other: Nil per os
Patients will receive no pre-operative bowel prep. The will receive the standard care only.
Drug: Cefazolin · Drug: Metronidazole · Other: Nil per os
Laxative,used for bowel preparation
Also known as: Senokot
Laxative used for bowel preparation
Also known as: Pico-Salax
Oral antibiotic
Also known as: flagyl
Oral non-absorbable antibiotic
Intravenous antibiotic to be given on anesthesia induction and prior to incision as a prophylactic antibiotic.
Also known as: ancef
Intravenous antibiotic to be given on anesthesia induction and prior to incision as prophylactic antibiotic.
Also known as: Flagyl
Fasting orders according to anesthesia prior to surgery: No solid for \>=8 hours, no formula milk/full liquids \>= 4hours; no breast milk or clear fluids \>=2hours.
Also known as: NPO
As part of bowel preparation, participants will be asked to stick to clear fluids following breakfast the day before surgery. Breast milk is allowed if applicable.
Feasibility (no. enrolled)
recruitment rate (percentage of eligible patients enrolled and retained to the end of study).
Time frame: From randomization to 30 days post-operatively
rate of post-randomization exclusions
Patients excluded after being randomized
Time frame: From randomization to 30 days post-operatively
Protocol deviations
Number of protocol deviations
Time frame: From randomization to 30 days post-operatively
Adverse events
Any expected and unexpected adverse event, with grade of adverse event
Time frame: From randomization to 30 days post-operatively
Incomplete follow-up
Number missing follow-up appointments at 2 week mark
Time frame: From randomization to 30 days post-operatively
Superficial Incisional surgical site infection (SSI)
Rate of SI-SSI (superficial or deep, number of patients who developed SSI per group/subgroup).
Time frame: 30 days post-operatively.
Deep incisional surgical site infection (SSI)
Rate of DI-SSI (number of patients who developed SSI per group/subgroup).
Time frame: 30 days post-operatively.
Organ space - Surgical site infection (SSI)
Rate of OS- SSI (number of patients who developed OS-SSI per group/subgroup).
Time frame: 30 days post-operatively.
Anastomotic leak - Surgical site infection (SSI)
Rate of anastomotic leak (verified by a contrast study or intra-operatively) (number of patients who developed OS-SSI per group/subgroup).
Time frame: 30 days post-operatively.
Length of hospital stay
Post-operative hospitalization on primary admission in days
Time frame: 30 days post-operatively.
Time to full enteric feed.
Post-operative return to full feed/diet in days
Time frame: 30 days post-operatively.
Re-admission
admission in post-operative period for a reason related to the surgery (yes/No)
Time frame: 30 days post-operatively.
Re-operation
Yes/No. Note:operation indication is directly related to the surgery
Time frame: 30 days post-operatively.
Electrolyte disturbance
significant changes in electrolytes (abnormal levels) (Yes/No)
Time frame: On day of surgery
Electrolyte disturbance
If abnormal levels were detected, whether this was associate by clinical signs (Yes/No)
Time frame: On day of surgery
Clostridium difficile infection
Occurrence of C. difficile infection post-operatively (Yes/No)
Time frame: 30 days post-operatively.
No study locations are listed for this record.
Plan to share: No
This study is status unknown, as verified in Nov 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
McMaster University